These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18427761)

  • 41. Hemolytic-uremic syndrome caused by gemcitabine.
    Nackaerts K; Daenen M; Vansteenkiste J; Vandevelde A; Van Bleyenbergh P; Demedts M
    Ann Oncol; 1998 Dec; 9(12):1355. PubMed ID: 9932169
    [No Abstract]   [Full Text] [Related]  

  • 42. Severe hemolytic uremic syndrome in an advanced ovarian cancer patient treated with carboplatin and gemcitabine.
    Gross M; Hiesse C; Kriaa F; Goldwasser F
    Anticancer Drugs; 1999 Jul; 10(6):533-6. PubMed ID: 10885900
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of thrombotic thrombocytopenic purpura after a single dose of gemcitabine.
    De Smet D; Jochmans K; Neyns B
    Ann Hematol; 2008 Jun; 87(6):495-6. PubMed ID: 18097666
    [No Abstract]   [Full Text] [Related]  

  • 44. Elevated reticulocyte count--a clue to the diagnosis of haemolytic-uraemic syndrome (HUS) associated with gemcitabine therapy for metastatic duodenal papillary carcinoma: a case report.
    Serke S; Riess H; Oettle H; Huhn D
    Br J Cancer; 1999 Mar; 79(9-10):1519-21. PubMed ID: 10188900
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Foot manifestations of the thrombotic thrombocytopenic purpura hemolytic-uremic syndrome: a review and case report.
    Bibbo C; Davis WH
    J Foot Ankle Surg; 2005; 44(4):301-6. PubMed ID: 16012439
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Three cases of hemolytic uremic syndrome in ovarian cancer patients treated with combination gemcitabine and pegylated liposomal doxorubicin.
    Lewin SN; Mutch DG; Whitcomb BP; Liapis H; Herzog TJ
    Gynecol Oncol; 2005 Apr; 97(1):228-33. PubMed ID: 15790464
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rituximab to treat gemcitabine-induced hemolytic-uremic syndrome (HUS) in pancreatic adenocarcinoma: a case series and literature review.
    Ritchie GE; Fernando M; Goldstein D
    Cancer Chemother Pharmacol; 2017 Jan; 79(1):1-7. PubMed ID: 27497971
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution.
    Müller S; Schütt P; Bojko P; Nowrousian MR; Hense J; Seeber S; Moritz T
    Ann Hematol; 2005 Feb; 84(2):110-4. PubMed ID: 15340761
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [42-year-old patient with renal insufficience, anemia and thrombocytopenia during chemotherapy].
    Schoel G; Schrader J; Bäsecke J
    Dtsch Med Wochenschr; 2020 Apr; 145(8):523-524. PubMed ID: 32294777
    [No Abstract]   [Full Text] [Related]  

  • 50. [Thrombotic microangiopathy : Relevant new aspects for intensive care physicians].
    Gaggl M; Aigner C; Sunder-Plassmann G; Schmidt A
    Med Klin Intensivmed Notfmed; 2016 Jun; 111(5):434-9. PubMed ID: 27255224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thrombotic microangiopathy.
    Mörtzell M; Berlin G; Nilsson T; Axelsson CG; Efvergren M; Audzijoni J; Griskevicius A; Ptak J; Blaha M; Tomsova H; Liumbruno GM; Centoni P; Newman E; Eloot S; Dhondt A; Tomaz J; Witt V; Rock G; Stegmayr B
    Transfus Apher Sci; 2011 Oct; 45(2):119-23. PubMed ID: 21885345
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mitomycin--C-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: cumulative toxicity of an old drug in a new era.
    El-Ghazal R; Podoltsev N; Marks P; Chu E; Saif MW
    Clin Colorectal Cancer; 2011 Jun; 10(2):142-5. PubMed ID: 21859568
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Thrombotic microangiopathy in adults].
    Barrientos GJ; Michelangelo H
    Medicina (B Aires); 2006; 66(4):289-95. PubMed ID: 16977962
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reversible renal-limited thrombotic microangiopathy due to gemcitabine-dexamethasone-cisplatin therapy: a case report.
    Nishikubo M; Shimomura Y; Hiramoto N; Sawamura N; Yamaguchi T; Hara S; Ishikawa T
    BMC Nephrol; 2021 May; 22(1):175. PubMed ID: 33980166
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gemcitabine and haemolytic-uraemic syndrome.
    Ruiz I; Del Valle J; Gómez A
    Ann Oncol; 2004 Oct; 15(10):1575-6. PubMed ID: 15367421
    [No Abstract]   [Full Text] [Related]  

  • 56. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon β.
    Larochelle C; Grand'maison F; Bernier GP; Latour M; Cailhier JF; Prat A
    Mult Scler; 2014 Nov; 20(13):1783-7. PubMed ID: 24534079
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Concomitant acral necrosis and haemolytic uraemic syndrome following ingestion of quinine.
    Agarwal N; Cherascu B
    J Postgrad Med; 2002; 48(3):197-8. PubMed ID: 12432194
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [On primary and secondary malignant nephrosclerosis (author's transl)].
    Bohle A; Helmchen U; Meyer D; Bock KD; Brüning L; Edel HH; Heimsoth V; Scheler F
    Klin Wochenschr; 1973 Sep; 51(17):841-57. PubMed ID: 4795732
    [No Abstract]   [Full Text] [Related]  

  • 59. Quinine induced HUS-TTP: an unusual presentation.
    Baliga RS; Wingo CS
    Am J Med Sci; 2003 Dec; 326(6):378-80. PubMed ID: 14671503
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes.
    Kojouri K; Vesely SK; George JN
    Ann Intern Med; 2001 Dec; 135(12):1047-51. PubMed ID: 11747383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.